Triptans are ruled out for anyone with established cardiovascular disease: ischemic heart disease, a prior heart attack, coronary vasospasm, uncontrolled high blood pressure or a history of stroke or TIA. Serious cardiovascular events from triptans are rare and happen mostly in people who have it (Dodick et al., 2004). The list is specific, and shorter than most people expect.
Why triptans carry a cardiovascular screen at all
Triptans are 5-HT1B/1D receptor agonists. They stop a migraine partly by constricting dilated cranial blood vessels. That constriction is not perfectly selective. It reaches coronary arteries and other vessels too, usually to a small degree, and that is the reason the drug class carries a list of cardiovascular contraindications. In a healthy vessel the effect is minor and passes quickly. In a vessel that is already narrowed or prone to spasm, the same effect is the concern.
So the screen is not caution for its own sake. It exists to keep triptans away from the small group of people whose vessels cannot absorb even a mild squeeze.
The conditions that rule you out
These are the absolute contraindications shared across the triptan class, including sumatriptan and rizatriptan. If any of them applies, a prescriber will not authorize a triptan and will look at a different acute treatment.
| Condition | Why it rules out triptans |
|---|---|
| Ischemic heart disease: angina, prior heart attack or documented silent ischemia | Coronary constriction can provoke ischemia in a vessel that is already narrowed. |
| Coronary artery vasospasm, including Prinzmetal angina | The same constriction can trigger spasm in vessels prone to it. |
| Uncontrolled high blood pressure | Triptans raise blood pressure briefly, and an uncontrolled baseline compounds the risk. |
| History of stroke or TIA | A prior cerebrovascular event signals vessels that do not tolerate constriction. |
| Peripheral vascular disease or ischemic bowel disease | Vasoconstriction extends beyond the head and can cut flow in an affected vessel. |
| Wolff-Parkinson-White syndrome or an accessory-pathway arrhythmia | The labels contraindicate triptans in these conduction disorders. |
| Hemiplegic or basilar migraine | These subtypes were excluded from the triptan trials and carry their own stroke concern. |
What the data shows
The reason this list matters is that when it is applied, triptans hold up well in real-world use.
A review of clinical-trial, postmarketing and pharmacodynamic data found that serious cardiovascular events from triptans are extremely rare, and that when they do occur they are most often in people who already have significant cardiovascular risk or overt cardiovascular disease (Dodick et al., 2004). Chest tightness during a triptan is common, but it is usually not cardiac in origin and usually not ischemic.
The population data points the same way. A cohort study drawn from UK general practice followed 63,575 people with migraine, of whom 13,664 were prescribed a triptan (Hall et al., 2004). Triptan prescription showed no association with stroke (hazard ratio 1.13, 95% CI 0.78 to 1.65) or heart attack (hazard ratio 0.93, 95% CI 0.60 to 1.43). Two things drive that result. Migraine itself carries some vascular risk, and the people not given a triptan had higher rates of stroke and ischemic heart disease. And triptans were prescribed to patients who were at lower cardiovascular risk to begin with, because the screen sends higher-risk patients toward other treatments. The safety record in practice is a product of the screen working, not evidence that the screen is unnecessary.
Risk factors are not the same as a contraindication
This is where many people talk themselves out of a treatment they could safely use. Having a cardiovascular risk factor is not the same as having cardiovascular disease. Controlled high blood pressure on medication, high cholesterol, diabetes, being a smoker, being past menopause or being over 40 with a family history of heart disease does not automatically disqualify you. What it does is trigger a closer look. For someone with risk factors but no diagnosed heart disease, a prescriber may want a cardiovascular assessment before the first dose, rather than a flat refusal.
| Rules you out | Needs review, not an automatic no |
|---|---|
| Diagnosed coronary artery disease or prior heart attack | Controlled high blood pressure on treatment |
| Stroke or TIA history | High cholesterol, diabetes or current smoking without diagnosed heart disease |
| Coronary vasospasm | Being postmenopausal or over 40 with a family history of heart disease |
| Uncontrolled high blood pressure | Occasional palpitations without a diagnosed arrhythmia |
The interactions that also disqualify a dose
Two of your medications can rule out a triptan even when your heart is fine. Do not take a triptan within 24 hours of an ergot medication such as ergotamine or dihydroergotamine, or within 24 hours of another triptan, because stacking two vasoconstrictors compounds the effect. Do not take one within two weeks of a monoamine oxidase-A inhibitor, which slows the drug's breakdown. Rizatriptan also needs a lower dose alongside propranolol. Triptans combined with an SSRI or SNRI carry a smaller serotonin-syndrome caution, which is a reason to tell your prescriber what you take, not usually a reason to avoid the drug.
What this means if you have a diagnosis
If you have known heart disease, a triptan is not the path, and a prescriber will route you to acute options that do not constrict blood vessels, such as a gepant. If you have risk factors but no diagnosis, the honest answer is that it depends on the assessment. A real intake asks about your cardiac history and your medications for this reason, and some people will screen out. That is the screen doing its job, and it is why triptans stay limited to no more than 9 to 10 treatment days a month even for people who clear the cardiovascular check.
The bottom line
The conditions that disqualify you from triptans are specific: established ischemic heart disease, coronary vasospasm, uncontrolled blood pressure, a stroke or TIA history, peripheral vascular disease, certain arrhythmias and hemiplegic or basilar migraine. Risk factors short of diagnosed disease call for a closer look, not an automatic refusal. The rarity of serious events in practice is a direct result of that screen. If you already have a diagnosis and know which triptan suits your attacks, the cardiovascular check is the step that confirms it is safe for you.
This article is for general education and is not a substitute for personalized medical advice from a licensed clinician.